YETUNDE ADEOLA: Open Payments
NPI 1033314299 · MILLBURN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122 in 7 payments from 5 companies in 2025. Trend: 2023 $19 · 2024 $157 · 2025 $122
Food & beverage: $122
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: CAPLYTA, Qelbree, AUSTEDO XR, ABILIFY MAINTENA, FANAPT.
Industry payments across NJ — which companies pay providers there.
